We are live on ! Find out more
KTOVW

Kitov Pharma Ltd. Warrants
KTOVW

Delisted

KTOVW was delisted on the 23rd of November, 2020.

Back to rankings

1 hedge funds and large institutions have $3K invested in Kitov Pharma Ltd. Warrants in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

81% less capital invested

Capital invested by funds: $16K → $3K (-$13K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.82K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$14K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$3K +$1.82K +2,640 +102%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
– -$14K -20,027 Closed

KTOVW Hedge Fund Activity: Q4 2017 in Review

1 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q4 2017, worth a combined $3K — down 81% from $16K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of KTOVW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $1.82K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $14K sold.

  • 1 institutional investor held Kitov Pharma Ltd. Warrants (KTOVW) as of Q4 2017, down from 2 in Q3 2017.
  • Funds reported $3K of Kitov Pharma Ltd. Warrants stock for Q4 2017, down 81% quarter-over-quarter.
  • 0 funds opened new Kitov Pharma Ltd. Warrants positions in Q4 2017 and 1 closed out, a net change of -1 holder.
  • The largest Kitov Pharma Ltd. Warrants buyer in Q4 2017 was UBS Group, an estimated $1.82K added.
  • The largest Kitov Pharma Ltd. Warrants seller in Q4 2017 was Susquehanna International Group, an estimated $14K sold.

Based on aggregated 13F filings for Q4 2017.